SEC Form 4 · accession 0001061983-19-000023
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ching Jaw
Officer — SVP Finance & CFO
Period of report
Feb 26, 2019
Accepted (ET)
Mar 4, 2019 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2019 | A | 30,000 | $0.00 | A | 50,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F2 | $7.14 | Feb 26, 2019 | A | 14,268 | A | — | Feb 26, 2029 | Common Stock | 14,268 | 14,268 | D |
| Non-Qualified Stock Option (right to buy)F2 | $7.14 | Feb 26, 2019 | A | 35,732 | A | — | Feb 26, 2029 | Common Stock | 35,732 | 35,732 | D |
Explanation of responses
- F1This award shall vest over three years in annual installments: 40% one year from the date of grant, 40% two years from the date of grant and 20% three years from the date of grant.
- F2This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant.